Search Results - "Silva, Matheus Molina"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Revealing Temozolomide Resistance Mechanisms via Genome-Wide CRISPR Libraries by Rocha, Clarissa Ribeiro Reily, Reily Rocha, Alexandre, Molina Silva, Matheus, Rodrigues Gomes, Luciana, Teatin Latancia, Marcela, Andrade Tomaz, Marina, de Souza, Izadora, Karolynne Seregni Monteiro, Linda, Menck, Carlos Frederico Martins

    Published in Cells (Basel, Switzerland) (01-12-2020)
    “…Glioblastoma is a severe type of brain tumor with a poor prognosis and few therapy options. Temozolomide (TMZ) is one of these options, however, with limited…”
    Get full text
    Journal Article
  2. 2

    Melanopsin (Opn4) is an oncogene in cutaneous melanoma by de Assis, Leonardo Vinícius Monteiro, Lacerda, José Thalles, Moraes, Maria Nathália, Domínguez-Amorocho, Omar Alberto, Kinker, Gabriela Sarti, Mendes, Davi, Silva, Matheus Molina, Menck, Carlos Frederico Martins, Câmara, Niels Olsen Saraiva, Castrucci, Ana Maria de Lauro

    Published in Communications biology (13-05-2022)
    “…The search for new therapeutical targets for cutaneous melanoma and other cancers is an ongoing task. We expanded this knowledge by evaluating whether opsins,…”
    Get full text
    Journal Article
  3. 3

    DNA repair pathways and cisplatin resistance: an intimate relationship by Rocha, Clarissa Ribeiro Reily, Silva, Matheus Molina, Quinet, Annabel, Cabral-Neto, Januario Bispo, Menck, Carlos Frederico Martins

    Published in Clinics (São Paulo, Brazil) (01-01-2018)
    “…The main goal of chemotherapeutic drugs is to induce massive cell death in tumors. Cisplatin is an antitumor drug widely used to treat several types of cancer…”
    Get full text
    Journal Article
  4. 4

    The balance between NRF2/GSH antioxidant mediated pathway and DNA repair modulates cisplatin resistance in lung cancer cells by Silva, Matheus Molina, Rocha, Clarissa Ribeiro Reily, Kinker, Gabriela Sarti, Pelegrini, Alessandra Luiza, Menck, Carlos Frederico Martins

    Published in Scientific reports (27-11-2019)
    “…Lung cancer patients face a dismal prognosis mainly due to the low efficacy of current available treatments. Cisplatin is the first-line chemotherapy treatment…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Loss of Melanopsin (OPN4) Leads to a Faster Cell Cycle Progression and Growth in Murine Melanocytes by de Assis, Leonardo Vinícius Monteiro, Moraes, Maria Nathália, Mendes, Davi, Silva, Matheus Molina, Menck, Carlos Frederico Martins, Castrucci, Ana Maria de Lauro

    Published in Current issues in molecular biology (04-10-2021)
    “…Skin melanocytes harbor a complex photosensitive system comprised of opsins, which were shown, in recent years, to display light- and thermo-independent…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9